The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 16 October 2006 doi:10.1084/jem.20061292
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 11, 2425-2431
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1705K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Correction (v203,p2563)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roulland, S.
Right arrow Articles by Nadel, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roulland, S.
Right arrow Articles by Nadel, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

 Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis

Sandrine Roulland1,2,3, Jean-Marc Navarro1,2,3, Pierre Grenot1,2,3, Michèle Milili1,2,3, Julie Agopian1,2,3, Bertrand Montpellier1,2,3, Pascal Gauduchon4, Pierre Lebailly4,5, Claudine Schiff1,2,3, and Bertrand Nadel1,2,3

1 Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, 13288 Marseille, France
2 Institut National de la Santé et de la Recherche Médicale (INSERM), U631, 13288 Marseille, France
3 Centre National de la Recherche Scientifique (CNRS), UMR6102, 13288 Marseille, France
4 Groupe Régional d'Etudes sur le Cancer EA1772, Université de Caen Basse-Normandie, CLCC François BACLESSE, 14076 Caen, France
5 Registre général des tumeurs du Calvados, CLCC François BACLESSE, 14076 Caen, France

CORRESPONDENCE Bertrand Nadel: nadel{at}ciml.univ-mrs.fr

Follicular lymphoma is one of the most common adult lymphoma, and remains virtually incurable despite its relatively indolent nature. t(14;18)(q32;q21) translocation, the genetic hallmark and early initiating event of follicular lymphoma (FL) pathogenesis, is also present at low frequency in the peripheral blood of healthy individuals. It has long been assumed that in healthy individuals t(14;18) is carried by circulating quiescent naive B cells, where its oncogenic potential would be restrained. Here, we question this current view and demonstrate that in healthy individuals, t(14;18) is actually carried by an expanding population of atypical B cells issued from germinal centers, displaying genotypic and phenotypic features of FL, and prone to constitute potent premalignant FL niches. These findings strongly impact both on the current understanding of disease progression and on the proper handling of t(14;18) frequency in blood as a potential early biomarker for lymphoma.

Abbreviations used in this paper: CSR, class-switch recombination; FL, follicular lymphoma; GC, germinal center; HI, healthy individuals; IGH, immunoglobulin heavy chain; LR-PCR, long-range PCR; SHM, somatic hypermutation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS